4QE-29363-52418 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-01-18
Registered in v-safe
2022-01-18
Dose 1 — Pfizer-BioNTech
2022-01-18
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Headache, Nausea

Adult check-in
2022-01-19
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2022-01-21
Survey response — days 1–6 daily, dose 1
MedDRA: Cough, Pharyngitis streptococcal — Feeling: Fair · Headache · Be unable to work or attend school

Free text: Coughing, Strep Throat

MedDRA releases: 2024-11 · check-in free text available
2022-01-23
Survey response — days 1–6 daily, dose 1
MedDRA: Nasal congestion — Feeling: Fair · Fever · Headache

Free text: Stuffy nose

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-01-18	Pfizer-BioNTech	No

Free text

Release 11 — days 1–6 daily, dose 1

2022-01-21

Systemic reaction (other): Coughing, Strep Throat

2022-01-23

Systemic reaction (other): Stuffy nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Cough	·	·	✓
SRO	Nasal congestion	·	·	✓
SRO	Pharyngitis streptococcal	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release